Entera Bio - ADR (ENTX) Financials

$2.93

$-0.07 (-2.33%)

As on 08-Sep-2026 12:35EDT

Market cap

$519 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

70.3

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-7.37	-6.82	-7.31	-12.50	-9.06
Cash Flow from Investing Activities	--	-0.11	0.00	-0.02	-0.10	-0.02
Cash from Financing Activities	--	13.71	4.48	6.04	0.01	25.38
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.35	-0.25	-0.25	-0.30	-0.45	-0.42
Cash EPS ($)	--	-0.25	-0.25	-0.30	-0.45	-0.42
Adjusted Book Value ($)	--	0.28	0.21	0.35	0.41	0.79
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.16	-0.18	-0.25	-0.43	-0.32
Free Cash Flow per Share ($)	--	-0.16	-0.18	-0.25	-0.44	-0.32

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-104.26	-99.76	-78.59	-75.31	-79.11
ROE (%)	-167.26	-108.01	-103.34	-80.30	-76.17	-81.04
ROA (%)	-79.05	-90.13	-90.20	-71.42	-66.84	-68.26
EBIT Margin (%)	--	-27,235.71	-5,263.54	-63,285.71	-9,714.18	-2,139.58
Net Margin (%)	--	-27,235.71	-5,271.27	-63,492.86	-9,754.48	-2,134.33
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-0.77	11.93	-0.90	-0.77	0.56
EBIT Growth (%)	8.13	-20.07	-7.53	31.94	-6.55	-9.74
Net Profit Growth (%)	-60.66	-19.89	-7.33	31.99	-7.25	-22.08
EPS Growth (%)	-35.86	0.02	0.15	0.34	-0.07	0.22
Book Value Growth (%)	-60.91	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-7.83	-8.37	-2.01	-1.61	-6.62
Price / Book Value	70.30	6.84	9.88	1.72	1.79	3.58
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.52	-7.27	-7.53	-0.82	-0.68	-4.62
Close Price ($)	1.77	1.94	2.12	0.60	0.73	2.82
High Price ($)	3.22	3.22	3.35	1.48	3.51	10.16
Low Price ($)	0.91	1.50	0.58	0.52	0.47	1.07
Market Cap ($ Cr)	519.43	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.04	0.03	0.04	0.01	0.01
Short term debt to equity ratio	0.03	0.02	0.02	0.01	0.01	0.01
Current Ratio	8.98	3.23	7.63	10.32	9.58	8.01
Quick Ratio	8.98	--	--	--	9.80	--
Interest Coverage	-5.20	--	--	--	-0.50	-421.28

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	521.43	69.61	--	183.58	32.05
Asset Turnover	--	0.00	0.02	0.00	0.01	0.03
Receivable days	--	1,500.13	127.13	3,208.98	584.67	140.09
Inventory Days	--	--	--	-1,917.56	-1,063.20	-91.07
Payable days	--	2,521.96	228.28	326.12	330.89	161.57
Cash Conversion Cycle	--	--	--	965.30	-809.43	-112.55

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.